Tuesday, 31 January 2012

Clinical trial for secondary progressive MS

Source MS Trust:
A phase III trial, Ascend, involving 850 people in 15 countries will investigate the effectiveness of natalizumab (Tysabri) in secondary progressive MS.
Many people initially diagnosed with relapsing remitting MS (RRMS) find that over time the frequency of relapses decrease but disability gradually increases. This is known as secondary progressive MS.  For more click here.